Business
Where will Moderna be in 5 years?

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
Can you name a company that’s developing drugs for rare inherited illnesses, blocked arteries, and vaccines for infectious diseases you’ve never heard of? Since you clicked on this article, you already know that I’m talking about Moderna, (NASDAQ: MRNA) and not some pharma giant like Pfizer.
That’s right, by late 2025 Moderna should have its hands full with its efforts to move a selection of innovative treatments through their final clinical trials. In fact, its shareholders might be even more bullish about the company than they are today, with its coronavirus vaccine candidate on the verge of regulatory approval….
-
Noosa News24 hours ago
Alleged right boot bandit arrested after bizarre shoe heist at Kenmore shopping centre
-
Noosa News23 hours ago
Child sex offender pleads guilty to gardening at childcare centre where his wife worked
-
General23 hours ago
Keen as mustard • Inside Story
-
General23 hours ago
What are the rules for storage cages and shared garages in apartments?